Revascularized ST-segment elevation myocardial infarction. Temporal trends in contemporary therapies and impact on outcomes
To assess, in patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous intervention, the pace of introduction in clinical practice (2010-2017) of drug-eluting stents (DES), ticagrelor, prasugrel, and prolonged dual antiplatelet therapy (DAPT) duration, and...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Ribera, Aida [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2022 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
10 |
|---|
| Übergeordnetes Werk: |
Enthalten in: A brief review on experimental fluorosis - Perumal, Ekambaram ELSEVIER, 2013, publicación oficial de la Sociedad Española de Cardiologia, Madrid |
|---|---|
| Übergeordnetes Werk: |
volume:75 ; year:2022 ; number:8 ; pages:659-668 ; extent:10 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.rec.2021.10.011 |
|---|
| Katalog-ID: |
ELV058423702 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV058423702 | ||
| 003 | DE-627 | ||
| 005 | 20230625005346.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220808s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.rec.2021.10.011 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001842.pica |
| 035 | |a (DE-627)ELV058423702 | ||
| 035 | |a (ELSEVIER)S1885-5857(21)00323-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 570 |q VZ |
| 082 | 0 | 4 | |a 540 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 42.13 |2 bkl | ||
| 084 | |a 44.33 |2 bkl | ||
| 100 | 1 | |a Ribera, Aida |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Revascularized ST-segment elevation myocardial infarction. Temporal trends in contemporary therapies and impact on outcomes |
| 264 | 1 | |c 2022 | |
| 300 | |a 10 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a To assess, in patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous intervention, the pace of introduction in clinical practice (2010-2017) of drug-eluting stents (DES), ticagrelor, prasugrel, and prolonged dual antiplatelet therapy (DAPT) duration, and their potential impact on the risk of 2-year outcomes. | ||
| 650 | 7 | |a Prasugrel |2 Elsevier | |
| 650 | 7 | |a Effectiveness |2 Elsevier | |
| 650 | 7 | |a STEMI |2 Elsevier | |
| 650 | 7 | |a Ticagrelor |2 Elsevier | |
| 650 | 7 | |a DAPT |2 Elsevier | |
| 650 | 7 | |a Outcomes |2 Elsevier | |
| 650 | 7 | |a Revascularization |2 Elsevier | |
| 700 | 1 | |a Marsal, Josep R. |4 oth | |
| 700 | 1 | |a Faixedas, María T. |4 oth | |
| 700 | 1 | |a Rosas, Alba |4 oth | |
| 700 | 1 | |a Tizón-Marcos, Helena |4 oth | |
| 700 | 1 | |a Rojas, Sergio |4 oth | |
| 700 | 1 | |a Labata, Carlos |4 oth | |
| 700 | 1 | |a Cárdenas, Mérida |4 oth | |
| 700 | 1 | |a Homs, Silvia |4 oth | |
| 700 | 1 | |a Tomás-Querol, Carlos |4 oth | |
| 700 | 1 | |a García-Picart, Joan |4 oth | |
| 700 | 1 | |a Roura, Gerard |4 oth | |
| 700 | 1 | |a Masotti, Mónica |4 oth | |
| 700 | 1 | |a Mauri, Josepa |4 oth | |
| 700 | 1 | |a Pijoan, José Ignacio |4 oth | |
| 700 | 1 | |a Barrabés, José A. |4 oth | |
| 700 | 1 | |a Ferreira-González, Ignacio |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier España [u.a.] |a Perumal, Ekambaram ELSEVIER |t A brief review on experimental fluorosis |d 2013 |d publicación oficial de la Sociedad Española de Cardiologia |g Madrid |w (DE-627)ELV02195304X |
| 773 | 1 | 8 | |g volume:75 |g year:2022 |g number:8 |g pages:659-668 |g extent:10 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.rec.2021.10.011 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_130 | ||
| 912 | |a GBV_ILN_644 | ||
| 936 | b | k | |a 42.13 |j Molekularbiologie |q VZ |
| 936 | b | k | |a 44.33 |j Physiologische Chemie |q VZ |
| 951 | |a AR | ||
| 952 | |d 75 |j 2022 |e 8 |h 659-668 |g 10 | ||
| author_variant |
a r ar |
|---|---|
| matchkey_str |
riberaaidamarsaljoseprfaixedasmaratrosas:2022----:eaclrzdtemneeainycrilnacineprlrnsnotmoay |
| hierarchy_sort_str |
2022 |
| bklnumber |
42.13 44.33 |
| publishDate |
2022 |
| allfields |
10.1016/j.rec.2021.10.011 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001842.pica (DE-627)ELV058423702 (ELSEVIER)S1885-5857(21)00323-6 DE-627 ger DE-627 rakwb eng 570 VZ 540 VZ 610 VZ 610 VZ 42.13 bkl 44.33 bkl Ribera, Aida verfasserin aut Revascularized ST-segment elevation myocardial infarction. Temporal trends in contemporary therapies and impact on outcomes 2022 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To assess, in patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous intervention, the pace of introduction in clinical practice (2010-2017) of drug-eluting stents (DES), ticagrelor, prasugrel, and prolonged dual antiplatelet therapy (DAPT) duration, and their potential impact on the risk of 2-year outcomes. Prasugrel Elsevier Effectiveness Elsevier STEMI Elsevier Ticagrelor Elsevier DAPT Elsevier Outcomes Elsevier Revascularization Elsevier Marsal, Josep R. oth Faixedas, María T. oth Rosas, Alba oth Tizón-Marcos, Helena oth Rojas, Sergio oth Labata, Carlos oth Cárdenas, Mérida oth Homs, Silvia oth Tomás-Querol, Carlos oth García-Picart, Joan oth Roura, Gerard oth Masotti, Mónica oth Mauri, Josepa oth Pijoan, José Ignacio oth Barrabés, José A. oth Ferreira-González, Ignacio oth Enthalten in Elsevier España [u.a.] Perumal, Ekambaram ELSEVIER A brief review on experimental fluorosis 2013 publicación oficial de la Sociedad Española de Cardiologia Madrid (DE-627)ELV02195304X volume:75 year:2022 number:8 pages:659-668 extent:10 https://doi.org/10.1016/j.rec.2021.10.011 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_130 GBV_ILN_644 42.13 Molekularbiologie VZ 44.33 Physiologische Chemie VZ AR 75 2022 8 659-668 10 |
| spelling |
10.1016/j.rec.2021.10.011 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001842.pica (DE-627)ELV058423702 (ELSEVIER)S1885-5857(21)00323-6 DE-627 ger DE-627 rakwb eng 570 VZ 540 VZ 610 VZ 610 VZ 42.13 bkl 44.33 bkl Ribera, Aida verfasserin aut Revascularized ST-segment elevation myocardial infarction. Temporal trends in contemporary therapies and impact on outcomes 2022 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To assess, in patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous intervention, the pace of introduction in clinical practice (2010-2017) of drug-eluting stents (DES), ticagrelor, prasugrel, and prolonged dual antiplatelet therapy (DAPT) duration, and their potential impact on the risk of 2-year outcomes. Prasugrel Elsevier Effectiveness Elsevier STEMI Elsevier Ticagrelor Elsevier DAPT Elsevier Outcomes Elsevier Revascularization Elsevier Marsal, Josep R. oth Faixedas, María T. oth Rosas, Alba oth Tizón-Marcos, Helena oth Rojas, Sergio oth Labata, Carlos oth Cárdenas, Mérida oth Homs, Silvia oth Tomás-Querol, Carlos oth García-Picart, Joan oth Roura, Gerard oth Masotti, Mónica oth Mauri, Josepa oth Pijoan, José Ignacio oth Barrabés, José A. oth Ferreira-González, Ignacio oth Enthalten in Elsevier España [u.a.] Perumal, Ekambaram ELSEVIER A brief review on experimental fluorosis 2013 publicación oficial de la Sociedad Española de Cardiologia Madrid (DE-627)ELV02195304X volume:75 year:2022 number:8 pages:659-668 extent:10 https://doi.org/10.1016/j.rec.2021.10.011 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_130 GBV_ILN_644 42.13 Molekularbiologie VZ 44.33 Physiologische Chemie VZ AR 75 2022 8 659-668 10 |
| allfields_unstemmed |
10.1016/j.rec.2021.10.011 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001842.pica (DE-627)ELV058423702 (ELSEVIER)S1885-5857(21)00323-6 DE-627 ger DE-627 rakwb eng 570 VZ 540 VZ 610 VZ 610 VZ 42.13 bkl 44.33 bkl Ribera, Aida verfasserin aut Revascularized ST-segment elevation myocardial infarction. Temporal trends in contemporary therapies and impact on outcomes 2022 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To assess, in patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous intervention, the pace of introduction in clinical practice (2010-2017) of drug-eluting stents (DES), ticagrelor, prasugrel, and prolonged dual antiplatelet therapy (DAPT) duration, and their potential impact on the risk of 2-year outcomes. Prasugrel Elsevier Effectiveness Elsevier STEMI Elsevier Ticagrelor Elsevier DAPT Elsevier Outcomes Elsevier Revascularization Elsevier Marsal, Josep R. oth Faixedas, María T. oth Rosas, Alba oth Tizón-Marcos, Helena oth Rojas, Sergio oth Labata, Carlos oth Cárdenas, Mérida oth Homs, Silvia oth Tomás-Querol, Carlos oth García-Picart, Joan oth Roura, Gerard oth Masotti, Mónica oth Mauri, Josepa oth Pijoan, José Ignacio oth Barrabés, José A. oth Ferreira-González, Ignacio oth Enthalten in Elsevier España [u.a.] Perumal, Ekambaram ELSEVIER A brief review on experimental fluorosis 2013 publicación oficial de la Sociedad Española de Cardiologia Madrid (DE-627)ELV02195304X volume:75 year:2022 number:8 pages:659-668 extent:10 https://doi.org/10.1016/j.rec.2021.10.011 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_130 GBV_ILN_644 42.13 Molekularbiologie VZ 44.33 Physiologische Chemie VZ AR 75 2022 8 659-668 10 |
| allfieldsGer |
10.1016/j.rec.2021.10.011 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001842.pica (DE-627)ELV058423702 (ELSEVIER)S1885-5857(21)00323-6 DE-627 ger DE-627 rakwb eng 570 VZ 540 VZ 610 VZ 610 VZ 42.13 bkl 44.33 bkl Ribera, Aida verfasserin aut Revascularized ST-segment elevation myocardial infarction. Temporal trends in contemporary therapies and impact on outcomes 2022 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To assess, in patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous intervention, the pace of introduction in clinical practice (2010-2017) of drug-eluting stents (DES), ticagrelor, prasugrel, and prolonged dual antiplatelet therapy (DAPT) duration, and their potential impact on the risk of 2-year outcomes. Prasugrel Elsevier Effectiveness Elsevier STEMI Elsevier Ticagrelor Elsevier DAPT Elsevier Outcomes Elsevier Revascularization Elsevier Marsal, Josep R. oth Faixedas, María T. oth Rosas, Alba oth Tizón-Marcos, Helena oth Rojas, Sergio oth Labata, Carlos oth Cárdenas, Mérida oth Homs, Silvia oth Tomás-Querol, Carlos oth García-Picart, Joan oth Roura, Gerard oth Masotti, Mónica oth Mauri, Josepa oth Pijoan, José Ignacio oth Barrabés, José A. oth Ferreira-González, Ignacio oth Enthalten in Elsevier España [u.a.] Perumal, Ekambaram ELSEVIER A brief review on experimental fluorosis 2013 publicación oficial de la Sociedad Española de Cardiologia Madrid (DE-627)ELV02195304X volume:75 year:2022 number:8 pages:659-668 extent:10 https://doi.org/10.1016/j.rec.2021.10.011 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_130 GBV_ILN_644 42.13 Molekularbiologie VZ 44.33 Physiologische Chemie VZ AR 75 2022 8 659-668 10 |
| allfieldsSound |
10.1016/j.rec.2021.10.011 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001842.pica (DE-627)ELV058423702 (ELSEVIER)S1885-5857(21)00323-6 DE-627 ger DE-627 rakwb eng 570 VZ 540 VZ 610 VZ 610 VZ 42.13 bkl 44.33 bkl Ribera, Aida verfasserin aut Revascularized ST-segment elevation myocardial infarction. Temporal trends in contemporary therapies and impact on outcomes 2022 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier To assess, in patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous intervention, the pace of introduction in clinical practice (2010-2017) of drug-eluting stents (DES), ticagrelor, prasugrel, and prolonged dual antiplatelet therapy (DAPT) duration, and their potential impact on the risk of 2-year outcomes. Prasugrel Elsevier Effectiveness Elsevier STEMI Elsevier Ticagrelor Elsevier DAPT Elsevier Outcomes Elsevier Revascularization Elsevier Marsal, Josep R. oth Faixedas, María T. oth Rosas, Alba oth Tizón-Marcos, Helena oth Rojas, Sergio oth Labata, Carlos oth Cárdenas, Mérida oth Homs, Silvia oth Tomás-Querol, Carlos oth García-Picart, Joan oth Roura, Gerard oth Masotti, Mónica oth Mauri, Josepa oth Pijoan, José Ignacio oth Barrabés, José A. oth Ferreira-González, Ignacio oth Enthalten in Elsevier España [u.a.] Perumal, Ekambaram ELSEVIER A brief review on experimental fluorosis 2013 publicación oficial de la Sociedad Española de Cardiologia Madrid (DE-627)ELV02195304X volume:75 year:2022 number:8 pages:659-668 extent:10 https://doi.org/10.1016/j.rec.2021.10.011 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_130 GBV_ILN_644 42.13 Molekularbiologie VZ 44.33 Physiologische Chemie VZ AR 75 2022 8 659-668 10 |
| language |
English |
| source |
Enthalten in A brief review on experimental fluorosis Madrid volume:75 year:2022 number:8 pages:659-668 extent:10 |
| sourceStr |
Enthalten in A brief review on experimental fluorosis Madrid volume:75 year:2022 number:8 pages:659-668 extent:10 |
| format_phy_str_mv |
Article |
| bklname |
Molekularbiologie Physiologische Chemie |
| institution |
findex.gbv.de |
| topic_facet |
Prasugrel Effectiveness STEMI Ticagrelor DAPT Outcomes Revascularization |
| dewey-raw |
570 |
| isfreeaccess_bool |
false |
| container_title |
A brief review on experimental fluorosis |
| authorswithroles_txt_mv |
Ribera, Aida @@aut@@ Marsal, Josep R. @@oth@@ Faixedas, María T. @@oth@@ Rosas, Alba @@oth@@ Tizón-Marcos, Helena @@oth@@ Rojas, Sergio @@oth@@ Labata, Carlos @@oth@@ Cárdenas, Mérida @@oth@@ Homs, Silvia @@oth@@ Tomás-Querol, Carlos @@oth@@ García-Picart, Joan @@oth@@ Roura, Gerard @@oth@@ Masotti, Mónica @@oth@@ Mauri, Josepa @@oth@@ Pijoan, José Ignacio @@oth@@ Barrabés, José A. @@oth@@ Ferreira-González, Ignacio @@oth@@ |
| publishDateDaySort_date |
2022-01-01T00:00:00Z |
| hierarchy_top_id |
ELV02195304X |
| dewey-sort |
3570 |
| id |
ELV058423702 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV058423702</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625005346.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220808s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.rec.2021.10.011</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001842.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV058423702</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1885-5857(21)00323-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.33</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ribera, Aida</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Revascularized ST-segment elevation myocardial infarction. Temporal trends in contemporary therapies and impact on outcomes</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">To assess, in patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous intervention, the pace of introduction in clinical practice (2010-2017) of drug-eluting stents (DES), ticagrelor, prasugrel, and prolonged dual antiplatelet therapy (DAPT) duration, and their potential impact on the risk of 2-year outcomes.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Prasugrel</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Effectiveness</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">STEMI</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ticagrelor</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DAPT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Outcomes</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Revascularization</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Marsal, Josep R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Faixedas, María T.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rosas, Alba</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tizón-Marcos, Helena</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rojas, Sergio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Labata, Carlos</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cárdenas, Mérida</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Homs, Silvia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tomás-Querol, Carlos</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">García-Picart, Joan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Roura, Gerard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Masotti, Mónica</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mauri, Josepa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pijoan, José Ignacio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Barrabés, José A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ferreira-González, Ignacio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier España [u.a.]</subfield><subfield code="a">Perumal, Ekambaram ELSEVIER</subfield><subfield code="t">A brief review on experimental fluorosis</subfield><subfield code="d">2013</subfield><subfield code="d">publicación oficial de la Sociedad Española de Cardiologia</subfield><subfield code="g">Madrid</subfield><subfield code="w">(DE-627)ELV02195304X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:75</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:8</subfield><subfield code="g">pages:659-668</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.rec.2021.10.011</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_130</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_644</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.13</subfield><subfield code="j">Molekularbiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.33</subfield><subfield code="j">Physiologische Chemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">75</subfield><subfield code="j">2022</subfield><subfield code="e">8</subfield><subfield code="h">659-668</subfield><subfield code="g">10</subfield></datafield></record></collection>
|
| author |
Ribera, Aida |
| spellingShingle |
Ribera, Aida ddc 570 ddc 540 ddc 610 bkl 42.13 bkl 44.33 Elsevier Prasugrel Elsevier Effectiveness Elsevier STEMI Elsevier Ticagrelor Elsevier DAPT Elsevier Outcomes Elsevier Revascularization Revascularized ST-segment elevation myocardial infarction. Temporal trends in contemporary therapies and impact on outcomes |
| authorStr |
Ribera, Aida |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV02195304X |
| format |
electronic Article |
| dewey-ones |
570 - Life sciences; biology 540 - Chemistry & allied sciences 610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
570 VZ 540 VZ 610 VZ 42.13 bkl 44.33 bkl Revascularized ST-segment elevation myocardial infarction. Temporal trends in contemporary therapies and impact on outcomes Prasugrel Elsevier Effectiveness Elsevier STEMI Elsevier Ticagrelor Elsevier DAPT Elsevier Outcomes Elsevier Revascularization Elsevier |
| topic |
ddc 570 ddc 540 ddc 610 bkl 42.13 bkl 44.33 Elsevier Prasugrel Elsevier Effectiveness Elsevier STEMI Elsevier Ticagrelor Elsevier DAPT Elsevier Outcomes Elsevier Revascularization |
| topic_unstemmed |
ddc 570 ddc 540 ddc 610 bkl 42.13 bkl 44.33 Elsevier Prasugrel Elsevier Effectiveness Elsevier STEMI Elsevier Ticagrelor Elsevier DAPT Elsevier Outcomes Elsevier Revascularization |
| topic_browse |
ddc 570 ddc 540 ddc 610 bkl 42.13 bkl 44.33 Elsevier Prasugrel Elsevier Effectiveness Elsevier STEMI Elsevier Ticagrelor Elsevier DAPT Elsevier Outcomes Elsevier Revascularization |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
j r m jr jrm m t f mt mtf a r ar h t m htm s r sr c l cl m c mc s h sh c t q ctq j g p jgp g r gr m m mm j m jm j i p ji jip j a b ja jab i f g ifg |
| hierarchy_parent_title |
A brief review on experimental fluorosis |
| hierarchy_parent_id |
ELV02195304X |
| dewey-tens |
570 - Life sciences; biology 540 - Chemistry 610 - Medicine & health |
| hierarchy_top_title |
A brief review on experimental fluorosis |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV02195304X |
| title |
Revascularized ST-segment elevation myocardial infarction. Temporal trends in contemporary therapies and impact on outcomes |
| ctrlnum |
(DE-627)ELV058423702 (ELSEVIER)S1885-5857(21)00323-6 |
| title_full |
Revascularized ST-segment elevation myocardial infarction. Temporal trends in contemporary therapies and impact on outcomes |
| author_sort |
Ribera, Aida |
| journal |
A brief review on experimental fluorosis |
| journalStr |
A brief review on experimental fluorosis |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
500 - Science 600 - Technology |
| recordtype |
marc |
| publishDateSort |
2022 |
| contenttype_str_mv |
zzz |
| container_start_page |
659 |
| author_browse |
Ribera, Aida |
| container_volume |
75 |
| physical |
10 |
| class |
570 VZ 540 VZ 610 VZ 42.13 bkl 44.33 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Ribera, Aida |
| doi_str_mv |
10.1016/j.rec.2021.10.011 |
| dewey-full |
570 540 610 |
| title_sort |
revascularized st-segment elevation myocardial infarction. temporal trends in contemporary therapies and impact on outcomes |
| title_auth |
Revascularized ST-segment elevation myocardial infarction. Temporal trends in contemporary therapies and impact on outcomes |
| abstract |
To assess, in patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous intervention, the pace of introduction in clinical practice (2010-2017) of drug-eluting stents (DES), ticagrelor, prasugrel, and prolonged dual antiplatelet therapy (DAPT) duration, and their potential impact on the risk of 2-year outcomes. |
| abstractGer |
To assess, in patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous intervention, the pace of introduction in clinical practice (2010-2017) of drug-eluting stents (DES), ticagrelor, prasugrel, and prolonged dual antiplatelet therapy (DAPT) duration, and their potential impact on the risk of 2-year outcomes. |
| abstract_unstemmed |
To assess, in patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous intervention, the pace of introduction in clinical practice (2010-2017) of drug-eluting stents (DES), ticagrelor, prasugrel, and prolonged dual antiplatelet therapy (DAPT) duration, and their potential impact on the risk of 2-year outcomes. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_130 GBV_ILN_644 |
| container_issue |
8 |
| title_short |
Revascularized ST-segment elevation myocardial infarction. Temporal trends in contemporary therapies and impact on outcomes |
| url |
https://doi.org/10.1016/j.rec.2021.10.011 |
| remote_bool |
true |
| author2 |
Marsal, Josep R. Faixedas, María T. Rosas, Alba Tizón-Marcos, Helena Rojas, Sergio Labata, Carlos Cárdenas, Mérida Homs, Silvia Tomás-Querol, Carlos García-Picart, Joan Roura, Gerard Masotti, Mónica Mauri, Josepa Pijoan, José Ignacio Barrabés, José A. Ferreira-González, Ignacio |
| author2Str |
Marsal, Josep R. Faixedas, María T. Rosas, Alba Tizón-Marcos, Helena Rojas, Sergio Labata, Carlos Cárdenas, Mérida Homs, Silvia Tomás-Querol, Carlos García-Picart, Joan Roura, Gerard Masotti, Mónica Mauri, Josepa Pijoan, José Ignacio Barrabés, José A. Ferreira-González, Ignacio |
| ppnlink |
ELV02195304X |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.rec.2021.10.011 |
| up_date |
2024-07-06T18:58:36.535Z |
| _version_ |
1803857236103004160 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV058423702</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625005346.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220808s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.rec.2021.10.011</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001842.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV058423702</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1885-5857(21)00323-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.33</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ribera, Aida</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Revascularized ST-segment elevation myocardial infarction. Temporal trends in contemporary therapies and impact on outcomes</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">To assess, in patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous intervention, the pace of introduction in clinical practice (2010-2017) of drug-eluting stents (DES), ticagrelor, prasugrel, and prolonged dual antiplatelet therapy (DAPT) duration, and their potential impact on the risk of 2-year outcomes.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Prasugrel</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Effectiveness</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">STEMI</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ticagrelor</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DAPT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Outcomes</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Revascularization</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Marsal, Josep R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Faixedas, María T.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rosas, Alba</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tizón-Marcos, Helena</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rojas, Sergio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Labata, Carlos</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cárdenas, Mérida</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Homs, Silvia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tomás-Querol, Carlos</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">García-Picart, Joan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Roura, Gerard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Masotti, Mónica</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mauri, Josepa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pijoan, José Ignacio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Barrabés, José A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ferreira-González, Ignacio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier España [u.a.]</subfield><subfield code="a">Perumal, Ekambaram ELSEVIER</subfield><subfield code="t">A brief review on experimental fluorosis</subfield><subfield code="d">2013</subfield><subfield code="d">publicación oficial de la Sociedad Española de Cardiologia</subfield><subfield code="g">Madrid</subfield><subfield code="w">(DE-627)ELV02195304X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:75</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:8</subfield><subfield code="g">pages:659-668</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.rec.2021.10.011</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_130</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_644</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.13</subfield><subfield code="j">Molekularbiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.33</subfield><subfield code="j">Physiologische Chemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">75</subfield><subfield code="j">2022</subfield><subfield code="e">8</subfield><subfield code="h">659-668</subfield><subfield code="g">10</subfield></datafield></record></collection>
|
| score |
7.402647 |